Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 29 INDUSTRY 2 OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Thyroid Carcinoma, Anaplastic 1

Interventions

Cisplatin 49 Capecitabine 42 Radiotherapy 33 Oxaliplatin 33 Gemcitabine 33 apatinib 32 Cyclophosphamide 32 Drug Therapy 31 Paclitaxel 30 Carboplatin 29 tislelizumab 27 Irinotecan 27 Fluorouracil 26 Docetaxel 26 Bevacizumab 23 Surgical Procedures, Operative 20 Nivolumab 19 pembrolizumab 18 fludarabine 18 Metformin 16 Exercise 16 Radiation 15 camrelizumab 14 S 1 (combination) 14 Control Groups 14 Blood Specimen Collection 14 Pemetrexed 13 Standard of Care 12 anlotinib 11 Neoadjuvant Therapy 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Histocompatibility Testing × Clear all

NCT01774279 2021-01-05

iNATT

Velindre NHS Trust

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡